Podcast 21 Feb 2025Can RNA drugs solve the obesity epidemic? This week, we have a conversation with Alessandro Toniolo, CEO of Resalis Therapeutics, about a non-coding RNA drug candidate that promotes sustainable weight loss. February 21, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 20 Feb 2025 3 promising biotech approaches to treat Hunter syndrome, a rare genetic disorder Discover three promising approaches being investigated to treat Hunter syndrome, a rare genetic disorder affecting children. February 20, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 19 Feb 2025 Trade war: how new U.S. tariffs will impact the biopharma industry The U.S. plans to impose trade tariffs on imports. How does this affect the biopharma industry? February 19, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Feb 2025 T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments T cell engagers represent a novel approach to tuning the immune system to target and kill tumor cells, expanding treatment options for cancer. February 18, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by Cytel 18 Feb 2025 Why the right software is key to efficient trial design Facing delays and inefficiencies in clinical trial design? Learn how the right software can solve key challenges and improve outcomes. February 18, 2025 - 7 minutesmins - By Jennifer Tsang Share WhatsApp Twitter Linkedin Email
In Depth 17 Feb 2025 Biotech’s legal storm: Why securities class action lawsuits are surging Find out about what’s behind the increase of securities class action lawsuits in the biotech industry and how to prevent them. February 17, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 14 Feb 2025Reversing cancer mechanisms to fight back against solid tumors This week, we have a conversation with Catalym’s Eugen Leo about Visugromab is a monoclonal antibody that neutralizes the tumor-derived growth differentiation factor-15. February 14, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 13 Feb 2025 Seven companies using metabolomics to decode biology Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine. February 13, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 13 Feb 2025 DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup Find out about a new AI-driven company that emerges from stealth today to create novel protein – Latent Labs. February 13, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 12 Feb 2025 Dendritic cell therapy: Diakonos, Northwest Biotherapeutics and Mendus push ahead with next-generation candidates Find out about the field of dendritic cell therapy, as several companies attempt to bring next-generation candidates through the clinic. February 12, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Feb 2025 12 ways biotechnology makes the world more sustainable Biotech companies are turning to biology for solutions to make all aspects of our lives more sustainable for the environment. February 11, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 10 Feb 2025 Monoclonal antibodies: are they the key to treating Alzheimer’s disease? A major stride in treating Alzheimer’s disease has been the development of monoclonal antibodies. February 10, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email